Skip to main content
TipRanks
Go Ultimate75% OFF

John S. Montalbano Insider Profile

11 Followers

John S. Montalbano, Director at AbCellera Biologics, holds 256.00K shares in AbCellera Biologics (Ticker: ABCL). Most recently, John S. Montalbano Bought 10,000 shares of AbCellera Biologics on Aug 18, 2026 for an estimated value of $110.30K.

John S. Montalbano's Trading History

ABCL
AbCellera Biologics
Aug 18, 2026DirectorInformative Buy110.30K$2.94M
ABCL
Insider Shares: 256.00K (0.08%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 18, 2026Informative Buy$110.30K10,000$11.03+6.80%
May 18, 2026Informative Buy$95.40K20,000$4.77+185.50%
Nov 26, 2025Informative Buy$178.00K50,000$3.56+226.30%
Mar 10, 2025Informative Buy$57.50K25,000$2.30+62.20%
Mar 07, 2025Informative Buy$140.40K60,000$2.34+48.00%

You May Also Like

John S. Montalbano insider profile FAQ

What is the percentage of profitable transactions made by John S. Montalbano?
The percentage of profitable transactions made by John S. Montalbano is 50%.
What is the average return per transaction made by John S. Montalbano?
The average return per transaction made by John S. Montalbano is 39.30%.
What stocks does John S. Montalbano hold?
John S. Montalbano holds: ABCL stocks.
What was John S. Montalbano’s latest transaction?
John S. Montalbano’s latest transaction was an Informative Buy of $110.30K.
What was John S. Montalbano's most profitable transaction?
John S. Montalbano’s most profitable transaction was an Informative Buy of ABCL stock on November 26, 2025. The return on the trade was 226.30%.
What is John S. Montalbano's role in AbCellera Biologics?
John S. Montalbano's role in AbCellera Biologics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.